HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Moshe Kotler Selected Research

Reboxetine (Vestra)

11/2013The effect of reboxetine co-administration with olanzapine on metabolic and endocrine profile in schizophrenia patients.
7/2009Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
4/2006Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Moshe Kotler Research Topics

Disease

35Schizophrenia (Dementia Praecox)
01/2017 - 07/2001
10Psychotic Disorders (Schizoaffective Disorder)
01/2006 - 01/2002
8Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2008 - 04/2002
6Weight Gain
05/2014 - 03/2004
6Gambling (Pathological Gambling)
01/2013 - 01/2005
6Infections
10/2012 - 04/2002
5Mental Disorders (Mental Disorder)
03/2008 - 01/2002
5Anxiety Disorders (Anxiety Disorder)
01/2008 - 01/2002
4Neoplasms (Cancer)
10/2021 - 04/2004
4Alzheimer Disease (Alzheimer's Disease)
01/2008 - 01/2002
4Panic Disorder (Panic Attack)
11/2007 - 03/2004
3Virus Diseases (Viral Diseases)
01/2020 - 05/2005
3Lymphoma (Lymphomas)
01/2016 - 07/2012
3Chronic Disease (Chronic Diseases)
01/2006 - 01/2003
2Major Depressive Disorder (Major Depressive Disorders)
01/2015 - 05/2012
2Hallucinations (Hallucination)
05/2012 - 02/2011
2Depressive Disorder (Melancholia)
02/2009 - 01/2007
2Bipolar Disorder (Manic Depressive Psychosis)
01/2007 - 07/2004
2Parkinsonian Disorders (Parkinsonism)
11/2005 - 09/2003
2Psychomotor Agitation (Akathisia)
11/2005 - 05/2003
2Interstitial Nephritis (Tubulointerstitial Nephritis)
11/2005 - 09/2004
2Necrosis
11/2005 - 12/2003
2Dementia (Dementias)
11/2004 - 01/2003
2Treatment-Resistant Schizophrenia
01/2004 - 01/2004
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2021
1Glioblastoma (Glioblastoma Multiforme)
10/2021
1Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
01/2020
1HIV Infections (HIV Infection)
06/2019
1Neurobehavioral Manifestations
04/2015
1Hyperlipidemias (Hyperlipidemia)
05/2014
1Obesity
11/2013
1Childhood Schizophrenia
10/2013
1Breast Neoplasms (Breast Cancer)
06/2013
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
03/2013
1Leukemia
07/2012
1Sleep Deprivation
08/2009

Drug/Important Bio-Agent (IBA)

16Antipsychotic Agents (Antipsychotics)IBA
05/2014 - 07/2001
7DNA (Deoxyribonucleic Acid)IBA
06/2013 - 12/2002
7Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
03/2013 - 03/2004
5Clozapine (Clozaril)FDA LinkGeneric
10/2013 - 07/2001
5Dehydroepiandrosterone (DHEA)IBA
07/2007 - 02/2003
4Olanzapine (Zyprexa)FDA Link
01/2016 - 01/2004
3Pharmaceutical PreparationsIBA
06/2019 - 07/2004
3Norepinephrine (Noradrenaline)FDA LinkGeneric
11/2013 - 01/2006
3Reboxetine (Vestra)IBA
11/2013 - 04/2006
3salicylhydroxamic acid (SHAM)IBA
05/2012 - 03/2004
3Risperidone (Risperdal Consta)FDA LinkGeneric
12/2008 - 01/2003
3AntibodiesIBA
07/2008 - 12/2003
3Paroxetine (Paxil)FDA LinkGeneric
11/2007 - 03/2004
3Fluvoxamine (Luvox)FDA LinkGeneric
11/2007 - 01/2005
3NeurosteroidsIBA
07/2007 - 02/2003
3Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
01/2006 - 12/2002
3Cholinergic Agents (Cholinergics)IBA
11/2004 - 01/2003
3Cholinesterase Inhibitors (Anticholinesterases)IBA
11/2004 - 01/2003
3Antidepressive Agents (Antidepressants)IBA
03/2004 - 05/2002
21,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
06/2013 - 07/2012
2Biomarkers (Surrogate Marker)IBA
01/2011 - 11/2004
2Haloperidol (Haldol)FDA LinkGeneric
12/2008 - 01/2003
2CorticosteroneIBA
02/2008 - 12/2007
2Messenger RNA (mRNA)IBA
02/2008 - 12/2007
2Narcotic Antagonists (Opioid Antagonists)IBA
01/2008 - 12/2006
2Hydrocortisone (Cortisol)FDA LinkGeneric
07/2007 - 12/2004
2LithiumIBA
01/2007 - 06/2004
2Telomerase (Telomerase Reverse Transcriptase)IBA
11/2004 - 04/2004
2Donepezil (Aricept)FDA LinkGeneric
07/2004 - 01/2003
2Neurotransmitter Agents (Neurotransmitter)IBA
07/2004 - 12/2002
2CatecholaminesIBA
07/2004 - 12/2002
2Proteins (Proteins, Gene)FDA Link
01/2004 - 09/2002
2Cholecystokinin Receptors (Cholecystokinin Receptor)IBA
01/2004 - 10/2002
2Indicators and Reagents (Reagents)IBA
11/2003 - 07/2001
2Vitamin B 6IBA
09/2003 - 01/2002
2Serotonin (5 Hydroxytryptamine)IBA
05/2003 - 07/2001
2Peptide Hydrolases (Proteases)FDA Link
09/2002 - 04/2002
1Protein Subunits (Protein Subunit)IBA
01/2020
1Ritonavir (Norvir)FDA Link
06/2019
1NanocapsulesIBA
06/2019
1Cytochrome P-450 CYP3AIBA
06/2019
1LopinavirFDA Link
06/2019
1Peptides (Polypeptides)IBA
01/2016
1Paliperidone PalmitateFDA Link
01/2016
1ElementsIBA
01/2015
1Blood Glucose (Blood Sugar)IBA
05/2014
1ThymidineIBA
06/2013
1CytidineIBA
06/2013
1EscitalopramFDA Link
03/2013
1Biological ProductsIBA
01/2013
1CytosineIBA
10/2012
1Cytarabine (Cytosar-U)FDA LinkGeneric
10/2012
1Viral DNAIBA
10/2012
1Cytidine DeaminaseIBA
07/2012
1AutoantibodiesIBA
01/2011
1BaclofenFDA LinkGeneric
01/2011
1Acamprosate (Campral)FDA Link
01/2011

Therapy/Procedure

11Therapeutics
08/2009 - 01/2002
9Drug Therapy (Chemotherapy)
10/2021 - 02/2003
4Activities of Daily Living (ADL)
01/2017 - 11/2004
4Transcranial Magnetic Stimulation
01/2015 - 03/2004
2Institutionalization (Institutionalized Persons)
01/2006 - 12/2004
1Radiotherapy
07/2012
1Phototherapy (Light Therapy)
08/2009